Özlen Güzel-Akdemir
- Organic Chemistry top 2%
- Synthesis and Catalytic Reactions 19
- Synthesis and biological activity 14
- Synthesis and Biological Evaluation 6
- Synthesis and Characterization of Heterocyclic Compounds 5
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases 7
-
- Enzyme function and inhibition 24
- Phenothiazines and Benzothiazines Synthesis and Activities 15
- Cancer therapeutics and mechanisms 5
- Toxicology top 10%
- Co-authors
- Aydın SalmanClaudiu T. SupuranNilgün KaralıAndrea ScozzafavaAtilla AkdemirAlessio InnocentiSüheyla ÖzbeyNurten Özsoy
- Journals
- International Journal of Molecular Sciences (3 papers)Journal of Medicinal Chemistry (2 papers)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- TürkiyeItalyUnited States
In The Last Decade
Özlen Güzel-Akdemir
40 papers receiving 922 citations
Peers
Comparison fields: 5 of 64
- Organic Chemistry 776
- Physical and Theoretical Chemistry 132
- Pharmacology 202
- Molecular Biology 620
- Toxicology 20
Countries citing papers authored by Özlen Güzel-Akdemir
This map shows the geographic impact of Özlen Güzel-Akdemir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özlen Güzel-Akdemir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özlen Güzel-Akdemir more than expected).
Fields of papers citing papers by Özlen Güzel-Akdemir
This network shows the impact of papers produced by Özlen Güzel-Akdemir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özlen Güzel-Akdemir. The network helps show where Özlen Güzel-Akdemir may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Özlen Güzel-Akdemir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 4 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 8 | |
| 6 | 2020 | 6 | |
| 7 | 2020 | 29 | |
| 8 | 2016 | 24 | |
| 9 | 2013 | 22 | |
| 10 | 2013 | 14 | |
| 11 | 2013 | 22 | |
| 12 | 2011 | 44 | |
| 13 | 2010 | 20 | |
| 14 | 2009 | 29 | |
| 15 | 2009 | 36 | |
| 16 | 2009 | 16 | |
| 17 | 2009 | 122 | |
| 18 | 2008 | 22 | |
| 19 | 2007 | 47 | |
| 20 | 2006 | 36 |
About Özlen Güzel-Akdemir
Özlen Güzel-Akdemir is a scholar working on Organic Chemistry, Pharmacology and Physical and Theoretical Chemistry, having authored 41 papers that have together received 951 indexed citations. Recurring topics across this work include Enzyme function and inhibition (24 papers), Synthesis and Catalytic Reactions (19 papers), Phenothiazines and Benzothiazines Synthesis and Activities (15 papers), Synthesis and biological activity (14 papers), Cholinesterase and Neurodegenerative Diseases (7 papers), Synthesis and Biological Evaluation (6 papers), Cancer therapeutics and mechanisms (5 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). The work is most often cited by research in Organic Chemistry (776 citations), Physical and Theoretical Chemistry (132 citations) and Pharmacology (202 citations). Özlen Güzel-Akdemir has collaborated with scholars based in Türkiye, Italy and United States. Frequent co-authors include Aydın Salman, Claudiu T. Supuran, Nilgün Karalı, Andrea Scozzafava, Atilla Akdemir, Alessio Innocenti, Süheyla Özbey, Nurten Özsoy, Alfonso Maresca and Alexandrù T. Balaban. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.